Afrocentric InvestmentJSE:ACT 52 EV-to-FCF is 1.73 as of Jun. 26, 2026. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.09 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 410 Healthcare Providers & Services companies, Afrocentric Investment ranks better than 94.63% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Afrocentric Investment's Enterprise Value is R804 Mil.
Afrocentric Investment's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was R466 Mil. Therefore, Afrocentric Investment's EV-to-FCF for today is 1.73.
The historical rank and industry rank for Afrocentric Investment's EV-to-FCF or its related term are showing as below:
JSE:ACT'
s EV-to-FCF Range Over the Past 10 Years
Min: -123.82 Med: -11.55 Max: 52.92
Current: 1.74
During the past 13 years, the highest EV-to-FCF of Afrocentric Investment was 52.92. The lowest was -123.82. And the median was -11.55.
JSE:ACT's EV-to-FCF is ranked better than 94.63% of 410
companies
in the Healthcare Providers & Services industry
Industry Median: 17.435
vs JSE:ACT: 1.74
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Afrocentric Investment's PE Ratio (TTM) for today is calculated as:
Afrocentric Investment's share price for today is R0.79.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Afrocentric Investment's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was R-1.519.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Afrocentric Investment's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's EV-to-FCF falls into.
Afrocentric Investment's current Enterprise Value is R804 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Afrocentric Investment's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was R466 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Afrocentric Investment (JSE:ACT) has a EV-to-FCF of 1.73 as of Jun. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Afrocentric Investment and its competitors. According to the industry distribution chart, Afrocentric Investment ranks #22 out of 410 companies in the Healthcare Providers & Services industry, placing it in the top 5.4%.
Is Afrocentric Investment's EV-to-FCF too high?
Afrocentric Investment's current EV-to-FCF is 1.73. The Healthcare Providers & Services industry median EV-to-FCF is 17.44. Afrocentric Investment's value of 1.73 is 90.1% below this industry median. Based on the distribution chart, Afrocentric Investment ranks #22 out of 410 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #22 out of 410 companies for EV-to-FCF. This places Afrocentric Investment in the top 5% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 17.44. Afrocentric Investment's value of 1.73 is 90.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.44, based on 410 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afrocentric Investment's current EV-to-FCF of 1.73 is 90.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Afrocentric Investment and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current EV-to-FCF is 1.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.09, compared to a current price of R0.79 — trading 62.2% below its estimated fair value. The current EV-to-FCF is 1.73 and 90.1% below the Healthcare Providers & Services industry median of 17.44. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current EV-to-FCF is 1.73 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.79 is trading 62.2% below its estimated GF Value™ of R2.09.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
EV-to-FCF: 1.73
GF Value™: R2.09 vs. price of R0.79 (62.2% below fair value)
Industry Position: 90.1% below the Healthcare Providers & Services median (#22 of 410)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score
Get the complete analysis for JSE:ACT
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
